NFKB1 and Huntington disease: mHTT interaction with the key kinase of the nuclear factor kappa B (NFKB) pathway—the inhibitor of kappa B kinase—has been shown to be one of the causes of increased cytokine production in primary HD immune cells in humans, via increased activation of the NFKB signaling cascade upon stimulation with lipopolysaccharide.